Posted by Michael Wonder on 17 May 2018
J&J CEO warns of 'unintended consequences' of Trump's drug-price reduction plan
16 May 2018 - "There are going to be changes in the pricing system" for prescription drugs, Johnson & Johnson chief Alex Gorsky acknowledges.
Johnson & Johnson Chairman and CEO Alex Gorsky told CNBC on Wednesday he expects the company's pharmaceutical business will be able to successfully navigate any changes in health care as a result of President Donald Trump's new plan aimed a reducing drug prices.
At the same time, Gorsky warned the Trump administration to be careful not to impose "unintended consequences" on the U.S. health-care system, which is incredibly complex. He did not elaborate.
